NM_000179.3(MSH6):c.3528_3532del (p.Leu1177fs) AND Lynch syndrome 5

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Aug 24, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003454531.1

Allele description [Variation Report for NM_000179.3(MSH6):c.3528_3532del (p.Leu1177fs)]

NM_000179.3(MSH6):c.3528_3532del (p.Leu1177fs)

Gene:

MSH6:mutS homolog 6 [Gene - OMIM - HGNC]

Variant type:

Deletion

Cytogenetic location:

2p16.3

Genomic location:

Preferred name:

NM_000179.3(MSH6):c.3528_3532del (p.Leu1177fs)

HGVS:

NC_000002.12:g.47804999_47805003del
NG_007111.1:g.26853_26857del
NG_008397.1:g.105674_105678del
NM_000179.3:c.3528_3532delMANE SELECT
NM_001281492.2:c.3138_3142del
NM_001281493.2:c.2622_2626del
NM_001281494.2:c.2622_2626del
NP_000170.1:p.Leu1177fs
NP_000170.1:p.Leu1177fs
NP_001268421.1:p.Leu1047fs
NP_001268422.1:p.Leu875fs
NP_001268423.1:p.Leu875fs
LRG_219t1:c.3528_3532del
LRG_219:g.26853_26857del
LRG_219p1:p.Leu1177fs
NC_000002.11:g.48032137_48032141del
NC_000002.11:g.48032138_48032142del
NM_000179.2:c.3528_3532del
NM_000179.2:c.3528_3532delACTTG

Protein change:

L1047fs

Links:

dbSNP: rs863225408

NCBI 1000 Genomes Browser:

rs863225408

Molecular consequence:

NM_000179.3:c.3528_3532del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001281492.2:c.3138_3142del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001281493.2:c.2622_2626del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001281494.2:c.2622_2626del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:: Lynch syndrome 5 (LYNCH5)
Synonyms:: Colorectal cancer, hereditary nonpolyposis, type 5; Hereditary non-polyposis colorectal cancer, type 5
Identifiers:: MONDO: MONDO:0013710; MedGen: C1833477; Orphanet: 144; OMIM: 614350

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004188268	Myriad Genetics, Inc.	criteria provided, single submitter (Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))	Pathogenic (Aug 24, 2023)	unknown	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004188268

Myriad Genetics, Inc.

criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))

Pathogenic
(Aug 24, 2023)

unknown

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Myriad Genetics, Inc., SCV004188268.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 8, 2024

ClinVar

Relating variation to medicine